Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right [Yahoo! Finance]
Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right
Does Aurinia's Tang-Led Leadership Overhaul Reshape the Bull Case for Aurinia Pharmaceuticals (AUPH)? [Yahoo! Finance]
Aurinia Pharmaceuticals: New Management, Continued Lupkynis Performance [Seeking Alpha]
MKT Capital Applauds Aurinia Pharmaceuticals' Management Transition [Yahoo! Finance]